Cargando…
Low dose IL‐2 suppress osteoclastogenesis in collagen‐induced arthritis via JNK dependent pathway
BACKGROUND: Rheumatoid arthritis (RA) is one of the most common chronic immune joint diseases, mainly involving blood vessels and small joints. The complex pathogenesis of RA greatly increases the difficulty of treatment. At present, the common hormone and immunosuppressive therapy are not effective...
Autores principales: | Sun, Han, Zhao, Yong, Wang, Kun, Zhu, Li, Dong, Jian, Zhao, Jie, Wang, Yimin, Li, Huan, Sun, Xiaoliang, Lu, Yunjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654429/ https://www.ncbi.nlm.nih.gov/pubmed/33098626 http://dx.doi.org/10.1002/iid3.364 |
Ejemplares similares
-
Salubrinal Alleviates Collagen-Induced Arthritis through Promoting P65 Degradation in Osteoclastogenesis
por: Wang, Ziyu, et al.
Publicado: (2021) -
Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis
por: Wang, Tingyu, et al.
Publicado: (2019) -
Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
por: Lee, Kyung-Ann, et al.
Publicado: (2019) -
IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats
por: Yago, Toru, et al.
Publicado: (2007) -
Mannan-Binding Lectin Attenuates Inflammatory Arthritis Through the Suppression of Osteoclastogenesis
por: Dong, Lijun, et al.
Publicado: (2019)